Biocon Ltd.
| BSE: 532523 | Sector: Health care |
| NSE: BIOCON | ISIN Code: INE376G01013 |
| BSE 00:00 | 16 May | 319.90 |
-6.55 (-2.01%) |
OPEN
329.00 |
HIGH
329.00 |
LOW
317.10 |
| NSE 00:00 | 16 May | 319.90 |
-6.25 (-1.92%) |
OPEN
326.15 |
HIGH
326.85 |
LOW
317.05 |
| OPEN | 329.00 |
| PREVIOUS CLOSE | 326.45 |
| VOLUME | 59485 |
| 52-Week high | 420.25 |
| 52-Week low | 314.90 |
| P/E | 444.31 |
| Mkt Cap.(Rs cr) | 38,407 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Biocon Ltd. (BIOCON) - Company Information
Biocon Ltd
Biocon Limited is India's largest and fully-integrated innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin) BASALOG (Glargine) CANMAb (Trastuzumab) BIOMAb-EGFR (Nimotuzumab) KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab) a 'first in class' anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of deve...> More
| COMPANY INFORMATION | |||||||
| Executive Chairperson : | Kiran Mazumdar Shaw | ||||||
| Vice Chairman : | John Shaw | ||||||
| Director : | Ravi Mazumdar | ||||||
| Independent Director : | Mary Harney | ||||||
| Independent Director : | Daniel M Bradbury | ||||||
| Independent Director : | Vijay Kumar Kuchroo | ||||||
| Independent Director : | M Damodaran | ||||||
| Independent Director : | Bobby Parikh | ||||||
| Company Secretary : | Mayank Verma | ||||||
| Managing Director & CEO : | SIDDHARTH MITTAL | ||||||
| Non Executive Director : | Eric Vivek Mazumdar | ||||||
| Additional Director : | Naina Lal Kidwai | ||||||
| AUDITOR : | BSR & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 20th KM Hosur Road Hebbagodi, Electronic City P O,Bangalore,Karnataka-560100 | |||||||
| Ph : 91-80-28082808 | |||||||
| WEBSITE : http://www.biocon.com | |||||||
| E-mail : co.secretary@biocon.com | |||||||
Quick Links for Biocon:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
